code stringlengths 4 12 | description stringlengths 2 264 | codetype stringclasses 8
values | context stringlengths 160 15.5k |
|---|---|---|---|
J9070 | HC Cyclophosphamide Inj Bu100mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
S2150 | Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; m | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9120 | Injection, dactinomycin, 0.5 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9200 | Injection, floxuridine, 500 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9266 | PEGASPARGASE VIAL 3750U 5ML SNIJ | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
30243G0 | Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
38211 | Tumor cell deplete of harvst | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9093 | CYCLOPHOSPHAMIDE LYOPHILIZED 100 MG | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9305 | pemetrexed per 10 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
38232 | PR BONE MARROW HARVEST TRANSPLANTATION AUTOLOGOUS | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9027 | Injection, clofarabine, 1 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9355 | trastuzumab per 10 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9357 | Valrubicin injection | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9216 | Interferon gamma 1-b inj | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9260 | METHOTREXATE SODIUM (PF) 50 MG/2ML INJ SOLUTION | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9211 | Injection, idarubicin hydrochloride, 5 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9215 | Interferon alfa-n3 inj | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9340 | Thiotepa injection | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9290 | Mitomycin 20 MG inj | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9025 | INJECTION, AZACITIDINE, 1 MG | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9300 | QUINACRINE HCL 10 CC/200 MGM | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
J9219 | Leuprolide acetate implant, 65 mg | HCPCS | |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic progenitor cell harvesting for transplantaion, per collection, allogeneic|
|38208||Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washin... |
90662 | INFLUENZA VIRUS VACCINE (IIV), SPLIT VIRUS, PRESERVATIVE FREE, ENHANCED IMMUNOGENICITY VIA INCREASED ANTIGEN CONTENT, FOR INTRAMUSCULAR USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90650 | HC 2VHPV VACCINE 3 DOSE SCHEDULE FOR IM USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90710 | VARICELLA VIRUS VACCINE LIVE 1350 PFU/0.5ML SC INJ | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90687 | Iiv4 vaccine splt 0.25 ml im | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
86762 | RUBELLA ANTIBODY | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90706 | Rubella vaccine sc | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90657 | HC IIV3 VACCINE SPLIT VIRUS 0.25 ML DOSAGE IM USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90689 | HC IIV4 VACC INACTIVATED PRSRV FR 0.25ML DOS IM US | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90734 | Meningococcal vaccine, serogroups A, C, W, Y, diphtheria toxoid carrier vaccine | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90715 | TETANUS, DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (TDAP), WHEN ADMINISTERED TO INDIVIDUALS 7 YEARS OR OLDER, FOR INTRAMUSCULAR USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
G0008 | PR ADMIN INFLUENZA VIRUS VAC | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90707 | MMR PVT | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90680 | ROTATEQ PVT | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90688 | HC IIV4 VACC SPLIT VIRUS 0.5 ML DOS FOR IM USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90686 | INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, PRESERVATIVE FREE, 0.5 ML DOSAGE, FOR INTRAMUSCULAR USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90649 | HC HUMAN PAPILOMA VAC 3 DOSE IM | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90673 | HC RIV3 VACCINE PRESERVATIVE FREE FOR IM USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90681 | HC RV1 VACCINE 2 DOSE SCHEDULE LIVE FOR ORAL USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90685 | HC IIV4 VACC PRSRV FREE 0.25 ML DOS FOR IM USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90633 | HEP A (PED) HAVRIX PVT | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90655 | Iiv3 vacc no prsv 0.25 ml im | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90651 | HC HUMAN PAPILOMA VAC 3 DOSE IM | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90661 | HC CCIIV3 VACCINE PRESERVATIVE FREE 0.5 ML IM USE | HCPCS | To help, the CDC has published vaccine catch-up guidance on their website. Important update from the National Committee for Quality Assurance (NCQA)
NCQA stressed the importance of getting childhood immunizations as soon as possible in a recent webinar, citing the impacts from the possible summer COVID-19 vaccine launc... |
90662 | INFLUENZA VIRUS VACCINE (IIV), SPLIT VIRUS, PRESERVATIVE FREE, ENHANCED IMMUNOGENICITY VIA INCREASED ANTIGEN CONTENT, FOR INTRAMUSCULAR USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90650 | HC 2VHPV VACCINE 3 DOSE SCHEDULE FOR IM USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90710 | VARICELLA VIRUS VACCINE LIVE 1350 PFU/0.5ML SC INJ | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90687 | Iiv4 vaccine splt 0.25 ml im | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
86762 | RUBELLA ANTIBODY | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90706 | Rubella vaccine sc | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90657 | HC IIV3 VACCINE SPLIT VIRUS 0.25 ML DOSAGE IM USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90689 | HC IIV4 VACC INACTIVATED PRSRV FR 0.25ML DOS IM US | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90734 | Meningococcal vaccine, serogroups A, C, W, Y, diphtheria toxoid carrier vaccine | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90715 | TETANUS, DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS VACCINE (TDAP), WHEN ADMINISTERED TO INDIVIDUALS 7 YEARS OR OLDER, FOR INTRAMUSCULAR USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
G0008 | PR ADMIN INFLUENZA VIRUS VAC | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90707 | MMR PVT | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90680 | ROTATEQ PVT | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90688 | HC IIV4 VACC SPLIT VIRUS 0.5 ML DOS FOR IM USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90686 | INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, PRESERVATIVE FREE, 0.5 ML DOSAGE, FOR INTRAMUSCULAR USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90649 | HC HUMAN PAPILOMA VAC 3 DOSE IM | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90673 | HC RIV3 VACCINE PRESERVATIVE FREE FOR IM USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90681 | HC RV1 VACCINE 2 DOSE SCHEDULE LIVE FOR ORAL USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90685 | HC IIV4 VACC PRSRV FREE 0.25 ML DOS FOR IM USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90633 | HEP A (PED) HAVRIX PVT | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90655 | Iiv3 vacc no prsv 0.25 ml im | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90651 | HC HUMAN PAPILOMA VAC 3 DOSE IM | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
90661 | HC CCIIV3 VACCINE PRESERVATIVE FREE 0.5 ML IM USE | HCPCS | Vaccine physicians are being advised that children should not receive any other vaccinations two weeks prior to or two weeks after receiving a COVID-19 vaccine. They re-emphasized the significance of delay and suggest that childhood immunizations are administered as soon as needed through proactively scheduling and pre... |
86580 | TUBERSOL PPD | HCPCS | The authors concluded that overall, a standard dose of IMVAMUNE (0.5 ml of 1 x 10(8) TCID/ml) administered subcutaneously was safe and well-tolerated. A 2nd dose of IMVAMUNE at day 28 compared to day 7 provided greater antibody responses and the maximal number of responders. By day 14 after the 2nd dose, IFN-γ ELISPOT ... |
86580 | TUBERSOL PPD | HCPCS | A 2nd dose of IMVAMUNE at day 28 compared to day 7 provided greater antibody responses and the maximal number of responders. By day 14 after the 2nd dose, IFN-γ ELISPOT responses were similar for Group: 0+28 and Group: 0+7. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for... |
86580 | TUBERSOL PPD | HCPCS | By day 14 after the 2nd dose, IFN-γ ELISPOT responses were similar for Group: 0+28 and Group: 0+7. |CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for clarification purposes. Codes requiring a 7th character are represented by "+":|
|ICD-10 codes will become effective as of O... |
E1340 | Repair for DME - per 15 min | CPT | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
A4556 | PT ELECTRODES | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
1999 | ANESTHESIOLOGY GROUP | CPT | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
E0608 | APNEA MONITOR | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
A4557 | Lead wires, pair | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
E0619 | Apnea monitor w recorder | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
E0618 | Apnea monitor, without recording feature | HCPCS | In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology mus... |
E1340 | Repair for DME - per 15 min | CPT | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
A4556 | PT ELECTRODES | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
1999 | ANESTHESIOLOGY GROUP | CPT | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
E0608 | APNEA MONITOR | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
A4557 | Lead wires, pair | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
E0619 | Apnea monitor w recorder | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
E0618 | Apnea monitor, without recording feature | HCPCS | The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language. 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies ... |
E1340 | Repair for DME - per 15 min | CPT | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
A4556 | PT ELECTRODES | HCPCS | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
1999 | ANESTHESIOLOGY GROUP | CPT | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
E0608 | APNEA MONITOR | HCPCS | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
A4557 | Lead wires, pair | HCPCS | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
E0619 | Apnea monitor w recorder | HCPCS | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
E0618 | Apnea monitor, without recording feature | HCPCS | 6/1992: Pneumogram policy approved by Medical Policy Advisory Committee (MPAC)
8/1992: Home Apnea Monitor policy approved by Medical Policy Advisory Committee (MPAC)
9/1999: Policies merged; interim policy changes made
11/1999: Revisions to interim policy approved by MPAC
2/27/2002: Managed Care Requirements deleted
3/... |
L8692 | Non-osseointegrated snd proc | HCPCS | Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated and ... |
L8692 | Non-osseointegrated snd proc | HCPCS | The coverage guidelines outlined in the Medical Policy should not be used in lieu of the Member's specific benefit plan language. POLICY HISTORY8/24/2007: Policy added
9/19/2007: Code reference section updated. ICD-9 2007 revisions added to policy
11/15/2007: Policy approved by MPAC
10/7/2008: Policy reviewed, no chang... |
L8692 | Non-osseointegrated snd proc | HCPCS | POLICY HISTORY8/24/2007: Policy added
9/19/2007: Code reference section updated. ICD-9 2007 revisions added to policy
11/15/2007: Policy approved by MPAC
10/7/2008: Policy reviewed, no changes
3/15/2010: Code Reference section updated. New HCPCS code L8692 added to covered table. 04/21/2010: Policy description updated ... |
L8692 | Non-osseointegrated snd proc | HCPCS | ICD-9 2007 revisions added to policy
11/15/2007: Policy approved by MPAC
10/7/2008: Policy reviewed, no changes
3/15/2010: Code Reference section updated. New HCPCS code L8692 added to covered table. 04/21/2010: Policy description updated regarding FDA approval of devices. The medically necessary policy statements were... |
L8692 | Non-osseointegrated snd proc | HCPCS | New HCPCS code L8692 added to covered table. 04/21/2010: Policy description updated regarding FDA approval of devices. The medically necessary policy statements were revised to add “5 years of age and older” to be consistent with FDA-approved labeling. “Sensorineural” added to the second statement. The intent of the po... |
L8693 | IMPL COCLR 4MM BAHA TI ABTMNT B1300 | HCPCS | The intent of the policy statements unchanged. FEP verbiage added to the Policy Exceptions section. 03/09/2011: Added new HCPCS code L8693 to the Code Reference section. 04/25/2011: Audiologic criteria moved from the policy guidelines to the policy statement. 03/02/2012: Added policy statement to indicate that partiall... |
L8693 | IMPL COCLR 4MM BAHA TI ABTMNT B1300 | HCPCS | FEP verbiage added to the Policy Exceptions section. 03/09/2011: Added new HCPCS code L8693 to the Code Reference section. 04/25/2011: Audiologic criteria moved from the policy guidelines to the policy statement. 03/02/2012: Added policy statement to indicate that partially implantable bone conduction hearing systems u... |
L8693 | IMPL COCLR 4MM BAHA TI ABTMNT B1300 | HCPCS | 03/09/2011: Added new HCPCS code L8693 to the Code Reference section. 04/25/2011: Audiologic criteria moved from the policy guidelines to the policy statement. 03/02/2012: Added policy statement to indicate that partially implantable bone conduction hearing systems using magnetic coupling for acoustic transmission are ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.